An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration
- 31 July 2008
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 156 (1), 106-111
- https://doi.org/10.1016/j.ahj.2007.12.035
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pravastatin Inhibits Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) in Watanabe Heritable Hyperlipidemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and DesignNeuroepidemiology, 2005
- Lovastatin Reduces Nuclear Factor κB Activation Induced by C-Reactive Protein in Human Vascular Endothelial CellsBiological & Pharmaceutical Bulletin, 2005
- Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cellsCardiovascular Research, 2004
- Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of actionBritish Journal of Pharmacology, 2004
- CRP as a Mediator of DiseaseCirculation, 2004
- C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the ElderlyCirculation, 2003
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40/CD40L Signaling in Human Coronary Artery Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002